The past 60 years have brought remarkable advancements in the diagnosis and treatment of
congenital heart disease (CHD). Early diagnosis and improvements in cardiac surgery and …

Tuberculosis (TB) is a possible complication of solid organ and hematopoietic stem cell
transplantation. The identification of candidates for preventive chemotherapy is an effective …

Endomyocardial biopsy (EMB) is an invasive procedure, globally most often used for the
monitoring of heart transplant (HTx) rejection. In addition, EMB can have an important …

Ross et al Transplantation in Congenital Heart Disease 803 listed ACHD patients are more
likely to experience cardiovascular death (including sudden death and death caused by HF) …

Endomyocardial biopsy (EMB) is an invasive procedure, globally most often used for the
monitoring of heart transplant rejection. In addition, EMB can have an important …

Significant practice-changing developments have occurred in the care of heart
transplantation candidates and recipients over the past decade. This Canadian …

Organ availability and acceptability limit pediatric HT x. What characteristics define an
unacceptable or high‐risk pediatric donor remains unclear. The purpose of this study was to …

More than 90% of children born with congenital heart disease (CHD) will survive to
adulthood, the beneficiaries of significant advances in neonatal corrective surgery, pediatric …

Background Little attention has focused on gender differences in cardiac comorbidities and
outcomes in patients undergoing orthotropic heart transplant. Objective The objective of this …

The progression of cardiovascular research is often impeded by the lack of reliable disease
models that fully recapitulate the pathogenesis in humans. These limitations apply to both in …